Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China.
BMJ Open Gastroenterol. 2024 Nov 14;11(1):e001587. doi: 10.1136/bmjgast-2024-001587.
Acute severe ulcerative colitis (ASUC) poses challenges to patient management owing to its high surgical rate. This study aimed to identify predictors of colectomy in patients with ASUC.
This is a systematic review and meta-analysis.
PubMed and Web of Science were searched up to April 2024.
Studies on the predictors of colectomy in adult patients with ASUC were eligible.
Two reviewers independently extracted the data using a prespecified data collection sheet. A qualitative synthesis was performed in tabular form. Random-effect meta-analyses were conducted using OR and 95% CI.
Forty-two studies were included in the systematic review. The reported variables can be categorised into biomarkers, auxiliary examination findings, demographic and clinical characteristics, and drug factors. Through meta-analysis, albumin (OR 0.39 (95% CI 0.26 to 0.59) per 1 g/dL increment, I=0.0%), high C reactive protein level (2.63 (1.53 to 4.52), I=29.6%), high erythrocyte sedimentation rate level (2.92 (1.39 to 6.14), I=0.0%), low haemoglobin level (2.08 (1.07 to 4.07), I=56.4%), fulfilling the Oxford criteria (4.42 (2.85 to 6.84), I=0.0%), extensive colitis (1.85 (1.24 to 2.78), I=47.5%), previous steroids (1.75 (1.23 to 2.50), I=17.7%) or azathioprine (2.25 (1.28 to 3.96), I=0.0%) use, and sarcopenia (1.90 (1.04 to 3.45), I=0.0%) were identified as valuable predictors for colectomy within 1 year. The ulcerative colitis endoscopic index of severity (OR 2.41 (95% CI 1.72 to 3.39), I=1.5%) was the only predictor found to predict colectomy over 1 year.
Identification of these predictors may facilitate risk stratification of patients with ASUC, drive personalised treatment and reduce the need for colectomy.
急性重度溃疡性结肠炎(ASUC)因其高手术率给患者管理带来挑战。本研究旨在确定 ASUC 患者行结肠切除术的预测因素。
这是一项系统评价和荟萃分析。
截至 2024 年 4 月,检索了 PubMed 和 Web of Science。
符合成人 ASUC 患者行结肠切除术预测因素研究的标准。
两名审查员使用预设的数据采集表独立提取数据。采用表格形式进行定性综合。使用 OR 和 95%CI 进行随机效应荟萃分析。
系统评价共纳入 42 项研究。报告的变量可分为生物标志物、辅助检查结果、人口统计学和临床特征以及药物因素。通过荟萃分析,白蛋白(每增加 1g/dL,OR 0.39(95%CI 0.26 至 0.59),I=0.0%)、高 C 反应蛋白水平(2.63(1.53 至 4.52),I=29.6%)、高红细胞沉降率水平(2.92(1.39 至 6.14),I=0.0%)、低血红蛋白水平(2.08(1.07 至 4.07),I=56.4%)、符合牛津标准(4.42(2.85 至 6.84),I=0.0%)、广泛性结肠炎(1.85(1.24 至 2.78),I=47.5%)、既往使用类固醇(1.75(1.23 至 2.50),I=17.7%)或硫唑嘌呤(2.25(1.28 至 3.96),I=17.7%)、肌肉减少症(1.90(1.04 至 3.45),I=0.0%)被认为是 1 年内行结肠切除术的有价值预测因素。溃疡性结肠炎内镜严重程度指数(OR 2.41(95%CI 1.72 至 3.39),I=1.5%)是唯一预测 1 年以上结肠切除术的预测因素。
识别这些预测因素可能有助于对 ASUC 患者进行风险分层,推动个体化治疗,并减少结肠切除术的需求。